[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Citations 0
Correction
June 15, 2005

Efficacy and Tolerability of Long-Acting Injectable Naltrexone for Alcohol Dependence: A Randomized Controlled Trial—Correction

JAMA. 2005;293(23):2864. doi:10.1001/jama.293.23.2864

Additional Financial Disclosure: Stephanie O'Malley, PhD, a coauthor of the Original Communication entitled “Efficacy and Tolerability of Long-Acting Injectable Naltrexone for Alcohol Dependence: A Randomized Controlled Trial” published in the April 6, 2005, issue of JAMA (2005;293:1617-1625) has reported an additional financial disclosure. Dr O'Malley is an inventor on a patent held by Yale University entitled “Smoking Cessation Treatments Using Naltrexone and Related Compounds.”

×